You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 166 No. 17, September 25, 2006 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Original Investigation
 •Online Features
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (136)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Aging/ Geriatrics
 •Treatment Adherence
 •Cardiovascular System
 •Cardiovascular Disease/ Myocardial Infarction
 •Drug Therapy
 •Adherence
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Impact of Medication Therapy Discontinuation on Mortality After Myocardial Infarction

P. Michael Ho, MD, PhD; John A. Spertus, MD, MPH; Frederick A. Masoudi, MD, MSPH; Kimberly J. Reid, MS; Eric D. Peterson, MD, MPH; David J. Magid, MD, MPH; Harlan M. Krumholz, MD, SM; John S. Rumsfeld, MD, PhD

Arch Intern Med. 2006;166:1842-1847.

Background  Nonadherence to medications is common, but the determinants and consequences are poorly defined. The objectives of this study were to identify patient and myocardial infarction (MI) treatment factors associated with medication therapy discontinuation and to assess the impact of medication discontinuation 1 month after MI on 12-month mortality.

Methods  This was a multicenter prospective cohort of patients with MI enrolled in the Prospective Registry Evaluating Myocardial Infarction: Event and Recovery study. The outcomes were use of aspirin, beta-blockers, and statins at 1 month after MI hospitalization among patients discharged with all 3 medications as well as 12-month mortality.

Results  Of 1521 patients discharged with all 3 medications, 184 discontinued use of all 3 medications, 56 discontinued use of 2 medications, 272 discontinued use of 1 medication, and 1009 continued taking all 3 medications at 1 month. In multivariable analyses, patients not graduating from high school (odds ratio [OR], 1.76; 95% confidence interval [CI], 1.20-2.60) were more likely to discontinue use of all medications. The effect of increasing age on medication therapy discontinuation was greater for females (OR, 1.77; 95% CI, 1.34-2.34) than males (OR, 1.23; 95% CI, 1.02-1.47). Patients who discontinued use of all medications at 1 month had lower 1-year survival (88.5% vs 97.7%; log-rank P<.001) compared with patients who continued to take 1 or more medication(s). In multivariable survival analysis, medication therapy discontinuation was independently associated with higher mortality (hazards ratio, 3.81; 95% CI, 1.88-7.72). Results were consistent when evaluating discontinuation of use of aspirin, beta-blockers, and statins separately.

Conclusions  Medication therapy discontinuation after MI is common and occurs early after discharge. Patients who discontinue taking evidence-based medications are at increased mortality risk. These findings suggest the need to improve the transition of care from the hospital to outpatient setting to ensure that patients continue to take medications that have mortality benefit.


Author Affiliations: Denver Veterans Affairs Medical Center (Drs Ho and Rumsfeld), University of Colorado Health Sciences Center (Drs Ho, Masoudi, Magid, and Rumsfeld), Mid American Heart Institute (Dr Spertus and Ms Reid), and Denver Health Medical Center (Dr Masoudi), Denver, Colo; Duke Clinical Research Institute, Durham, NC (Dr Peterson); Clinical Research Unit, Kaiser Permanente of Colorado, Aurora (Dr Magid); and Yale University School of Medicine, New Haven, Conn (Drs Magid and Krumholz).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Improving Medication Adherence: Challenges for Physicians, Payers, and Policy Makers
Patrick J. O’Connor
Arch Intern Med. 2006;166(17):1802-1804.
EXTRACT | FULL TEXT  

The Care Transitions Intervention: Results of a Randomized Controlled Trial
Eric A. Coleman, Carla Parry, Sandra Chalmers, and Sung-joon Min
Arch Intern Med. 2006;166(17):1822-1828.
ABSTRACT | FULL TEXT  

Cost-Related Medication Nonadherence Among Elderly and Disabled Medicare Beneficiaries: A National Survey 1 Year Before the Medicare Drug Benefit
Stephen B. Soumerai, Marsha Pierre-Jacques, Fang Zhang, Dennis Ross-Degnan, Alyce S. Adams, Jerry Gurwitz, Gerald Adler, and Dana Gelb Safran
Arch Intern Med. 2006;166(17):1829-1835.
ABSTRACT | FULL TEXT  

Effect of Medication Nonadherence on Hospitalization and Mortality Among Patients With Diabetes Mellitus
P. Michael Ho, John S. Rumsfeld, Frederick A. Masoudi, David L. McClure, Mary E. Plomondon, John F. Steiner, and David J. Magid
Arch Intern Med. 2006;166(17):1836-1841.
ABSTRACT | FULL TEXT  

Improved Therapeutic Monitoring With Several Interventions: A Randomized Trial
Adrianne C. Feldstein, David H. Smith, Nancy Perrin, Xiuhai Yang, Mary Rix, Marsha A. Raebel, David J. Magid, Steven R. Simon, and Stephen B. Soumerai
Arch Intern Med. 2006;166(17):1848-1854.
ABSTRACT | FULL TEXT  

Physician Communication When Prescribing New Medications
Derjung M. Tarn, John Heritage, Debora A. Paterniti, Ron D. Hays, Richard L. Kravitz, and Neil S. Wenger
Arch Intern Med. 2006;166(17):1855-1862.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Is There a Future for Endovascular Treatment of Intracranial Atherosclerotic Disease After Stenting and Aggressive Medical Management for Preventing Recurrent Stroke and Intracranial Stenosis (SAMMPRIS)?
Marks
Stroke 2012;43:580-584.
ABSTRACT | FULL TEXT  

A Randomized Controlled Trial of Positive-Affect Intervention and Medication Adherence in Hypertensive African Americans
Ogedegbe et al.
Arch Intern Med 2012;0:archinternmed.2011.1307v1-5.
ABSTRACT | FULL TEXT  

Treating dental patients who use oral antithrombotic medication: A survey of dentists in the Netherlands
van Diermen et al.
Journal of the American Dental Association 2011;142:1376-1382.
ABSTRACT | FULL TEXT  

Statin Use in Outpatients With Obstructive Coronary Artery Disease
Arnold et al.
Circulation 2011;124:2405-2410.
ABSTRACT | FULL TEXT  

Improving the validity of determining medication adherence from electronic health record medications orders
Carroll et al.
J Am Med Inform Assoc 2011;18:717-720.
ABSTRACT | FULL TEXT  

The Lessons of COURAGE for the Management of Stable Coronary Artery Disease
Kottke
J Am Coll Cardiol 2011;58:138-139.
FULL TEXT  

Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status (TRIUMPH): Design and Rationale of a Prospective Multicenter Registry
Arnold et al.
Circ Cardiovasc Qual Outcomes 2011;4:467-476.
ABSTRACT | FULL TEXT  

Statin discontinuation and risk of acute myocardial infarction in patients with rheumatoid arthritis: a population-based cohort study
De Vera et al.
Ann Rheum Dis 2011;70:1020-1024.
ABSTRACT | FULL TEXT  

Estimates of Statin Discontinuation Rates Are Influenced by Exposure and Outcome Definitions
Geers et al.
The Annals of Pharmacotherapy 2011;45:576-581.
ABSTRACT | FULL TEXT  

Meta-Analysis: Impact of Drug Class on Adherence to Antihypertensives
Kronish et al.
Circulation 2011;123:1611-1621.
ABSTRACT | FULL TEXT  

Aspirin Resistance: A Clinical Review Focused on the Most Common Cause, Noncompliance
Schwartz
The Neurohospitalist 2011;1:94-103.
ABSTRACT | FULL TEXT  

Which Interventions are Used by Health Care Professionals to Enhance Medication Adherence in Cardiovascular Patients? A Survey of Current Clinical Practice
Berben et al.
Eur J Cardiovasc Nurs 2011;10:14-21.
ABSTRACT | FULL TEXT  

Morbidity associated with three different antiplatelet regimens in patients undergoing implantation of cardiac rhythm management devices
Cano et al.
Europace 2011;13:395-401.
ABSTRACT | FULL TEXT  

Is prevention a fantasy, or the future of medicine? A panoramic view of recent data, status, and direction in cardiovascular prevention
Kones
Ther Adv Cardiovasc Dis 2011;5:61-81.
ABSTRACT  

Persistence With Stroke Prevention Medications 3 Months After Hospitalization
Bushnell et al.
Arch Neurol 2010;67:1456-1463.
ABSTRACT | FULL TEXT  

Use of Evidence-Based Therapy for the Prevention of Cardiovascular Events Among Older people
Castelino et al.
Eval Health Prof 2010;33:276-301.
ABSTRACT  

Optimal Medical Therapy for Non-ST-Segment-Elevation Acute Coronary Syndromes: Exploring Why Physicians Do Not Prescribe Evidence-Based Treatment and Why Patients Discontinue Medications After Discharge
Bagnall et al.
Circ Cardiovasc Qual Outcomes 2010;3:530-537.
ABSTRACT | FULL TEXT  

Predictors of Nonadherence to Statins: A Systematic Review and Meta-Analysis
Mann et al.
The Annals of Pharmacotherapy 2010;44:1410-1421.
ABSTRACT | FULL TEXT  

Aggregate National Experience With the Wearable Cardioverter-Defibrillator: Event Rates, Compliance, and Survival
Chung et al.
J Am Coll Cardiol 2010;56:194-203.
ABSTRACT | FULL TEXT  

Interventions to improve secondary prevention after stroke are needed: adherence to prescribed preventative drugs after stroke declines rapidly during the first 2 years after hospital discharge
Erickson and Eagle
Evid. Based Med. 2010;15:97-98.
FULL TEXT  

Delays in Filling Clopidogrel Prescription After Hospital Discharge and Adverse Outcomes After Drug-Eluting Stent Implantation: Implications for Transitions of Care
Ho et al.
Circ Cardiovasc Qual Outcomes 2010;3:261-266.
ABSTRACT | FULL TEXT  

Adherence to the medical regime in patients with heart failure
Muzzarelli et al.
Eur J Heart Fail 2010;12:389-396.
ABSTRACT | FULL TEXT  

The effect of optimal medical therapy on 1-year mortality after acute myocardial infarction
Bramlage et al.
Heart 2010;96:604-609.
ABSTRACT | FULL TEXT  

Rationale and Design of the Pharmacist Intervention for Low Literacy in Cardiovascular Disease (PILL-CVD) Study
Schnipper et al.
Circ Cardiovasc Qual Outcomes 2010;3:212-219.
ABSTRACT | FULL TEXT  

Potential survival gains in the treatment of myocardial infarction
Chew et al.
Heart 2009;95:1844-1850.
ABSTRACT | FULL TEXT  

Prothrombotic and Hemorrhagic Effects of Aspirin
Aguejouf et al.
CLIN APPL THROMB HEMOST 2009;15:523-528.
ABSTRACT  

Association between prescription burden and medication adherence in patients initiating antihypertensive and lipid-lowering therapy
Benner et al.
Am J Health Syst Pharm 2009;66:1471-1477.
ABSTRACT | FULL TEXT  

The Acute (Cerebro)Vascular Effects of Statins
Prinz and Endres
Anesth. Analg. 2009;109:572-584.
ABSTRACT | FULL TEXT  

Medication Adherence: Its Importance in Cardiovascular Outcomes
Ho et al.
Circulation 2009;119:3028-3035.
ABSTRACT | FULL TEXT  

Quality Improvement: Science and Action
Ting et al.
Circulation 2009;119:1962-1974.
FULL TEXT  

Mortality risk for diabetes patients in a care coordination, home-telehealth programme
Chumbler et al.
J Telemed Telecare 2009;15:98-101.
ABSTRACT | FULL TEXT  

Management of Hyperlipidemia in Older Adults
Alexander et al.
J CARDIOVASC PHARMACOL THER 2009;14:49-58.
ABSTRACT  

Heart Disease and Stroke Statistics--2009 Update: A Report From the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
WRITING GROUP MEMBERS et al.
Circulation 2009;119:e21-e181.
FULL TEXT  

Non-adherence to medicines: not solved but solvable
Elliott
J Health Serv Res Policy 2009;14:58-61.
ABSTRACT | FULL TEXT  

P4P4P: An Agenda For Research On Pay-For-Performance For Patients
Volpp et al.
Health Aff (Millwood) 2009;28:206-214.
ABSTRACT | FULL TEXT  

Depressive Symptoms, Health Behaviors, and Risk of Cardiovascular Events in Patients With Coronary Heart Disease
Whooley et al.
JAMA 2008;300:2379-2388.
ABSTRACT | FULL TEXT  

Global Secondary Prevention Strategies to Limit Event Recurrence After Myocardial Infarction: Results of the GOSPEL Study, a Multicenter, Randomized Controlled Trial From the Italian Cardiac Rehabilitation Network
Giannuzzi et al.
Arch Intern Med 2008;168:2194-2204.
ABSTRACT | FULL TEXT  

Improving Medication Adherence in Chronic Cardiovascular Disease
Albert
Crit Care Nurse 2008;28:54-64.
FULL TEXT  

Interaction between income and education in predicting long-term survival after acute myocardial infarction
Gerber et al.
European Journal of Cardiovascular Prevention & Rehabilitation 2008;15:526-532.
ABSTRACT | FULL TEXT  

Outcomes Research: Generating Evidence for Best Practice and Policies
Krumholz
Circulation 2008;118:309-318.
FULL TEXT  

A Randomized Trial of Direct-to-Patient Communication to Enhance Adherence to {beta}-Blocker Therapy Following Myocardial Infarction
Smith et al.
Arch Intern Med 2008;168:477-483.
ABSTRACT | FULL TEXT  

The Year in Epidemiology, Health Services Research, and Outcomes Research
Krumholz and Masoudi
J Am Coll Cardiol 2007;50:2254-2262.
FULL TEXT  

Discontinuation of Statin Therapy and Clinical Outcome After Ischemic Stroke
Colivicchi et al.
Stroke 2007;38:2652-2657.
ABSTRACT | FULL TEXT  

Self-reported Medication Adherence and Cardiovascular Events in Patients With Stable Coronary Heart Disease: The Heart and Soul Study
Gehi et al.
Arch Intern Med 2007;167:1798-1803.
ABSTRACT | FULL TEXT  

Persistent Use of Evidence-Based Pharmacotherapy in Heart Failure Is Associated With Improved Outcomes
Gislason et al.
Circulation 2007;116:737-744.
ABSTRACT | FULL TEXT  

Update in Cardiology
Frye
ANN INTERN MED 2007;147:180-186.
FULL TEXT  

Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology
Authors/Task Force Members et al.
Eur Heart J 2007;28:1598-1660.
FULL TEXT  

Outcomes of Myocardial Infarction in Hospitals With Percutaneous Coronary Intervention Facilities
Labarere et al.
Arch Intern Med 2007;167:913-920.
ABSTRACT | FULL TEXT  

Performance Measures and Outcomes for Patients Hospitalized With Heart Failure
Shishehbor and Litaker
JAMA 2007;297:1547-1547.
FULL TEXT  

ADDITIONAL ARTICLES ABSTRACTED IN ACP JOURNAL CLUB
Evid. Based Med. 2007;12:62-62.
FULL TEXT  

JournalScan
Lindsay
Heart 2007;93:409-410.
FULL TEXT  

Relationship Between Adherence to Evidence-Based Pharmacotherapy and Long-term Mortality After Acute Myocardial Infarction
Rasmussen et al.
JAMA 2007;297:177-186.
ABSTRACT | FULL TEXT  

Poor adherence to drug treatment increases mortality after a heart attack
BMJ 2006;333:.
FULL TEXT  

A Wake-Up Call About Medication Nonadherence
Journal Watch Cardiology 2006;2006:3-3.
FULL TEXT  

Improving medication adherence: challenges for physicians, payers, and policy makers.
O'Connor
Arch Intern Med 2006;166:1802-1804.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.